Live
ePaper
Search
Home > India > BRIEF-Kyorin Pharmaceutical Co Ltd – Kyorin And Acadia Pharmaceuticals Enter Into Distribution Agreement For Daybue Stix (Trofinetide) For Rett Syndrome In Japan

BRIEF-Kyorin Pharmaceutical Co Ltd – Kyorin And Acadia Pharmaceuticals Enter Into Distribution Agreement For Daybue Stix (Trofinetide) For Rett Syndrome In Japan

Written By:
Last Updated: November 16, 2026 12:10:28 IST

Nov 16 (Reuters) – Kyorin Pharmaceutical Co Ltd: * KYORIN PHARMACEUTICAL CO LTD: KYORIN AND ACADIA PHARMACEUTICALS ENTER INTO DISTRIBUTION AGREEMENT FOR DAYBUE STIX (TROFINETIDE) FOR RETT SYNDROME IN

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?